← Evidence map

ReviewCancer chemotherapy and pharmacology2026

The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials.

A C Kanhailal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42406058